Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Securities Class Action

Securities fraud litigation history and active cases

In Litigation

0

Settlement

2

Closed

0

Total Settlement

$22.95M

SPECTRUM PHARMACEUTICALS INC (SPPI) Class Action Lawsuit (December 2022)

Settlement

1:22cv10292 • December 5, 2022

Class Period Start

May 11, 2022

Class Period End

December 21, 2022

PSLRA Deadline

February 3, 2023

Case Allegations

10b5

Statutes of Repose

May 11, 2025

Country

United States

Court

Federal Court

Settlement Information

Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.

Claim Deadline

October 12, 2026

Settlement Fund

$7,000,000

Settlement Status

Preliminarily Approved

Settlement Class

All persons or entities that purchased the common stock of Spectrum Pharmaceuticals, Inc. (“Spectrum”) between May 12, 2022 and September 22, 2022, inclusive.

Claim Administrator

Strategic Claims Services
P.O. Box 230 600 N. Jackson St., Ste. 205 Media, PA 19063
+1 866-274-4004
[email protected]

Hearing Date

November 20, 2026

Opt-out Deadline

October 30, 2026

Settlement Note

Download here

Proof Of Claim

Download here

Docket History

Oct 16, 2026

Motion for Final Approval of Settlement

The parties have asked the court to grant final approval of the proposed settlement. The judge will consider whether the settlement should be approved after reviewing the settlement terms and any objections. If approved, eligible investors who submit valid claims may receive a payment after the claims review and distribution process is completed.

Jun 22, 2026

Preliminary Approval of Settlement

The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.

Jun 22, 2026

Notice of Pendency

Jun 22, 2026

Proof of Claim Form

To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.

Jun 1, 2026

Motion for Preliminary Approval of Settlement

The parties have asked the court to give preliminary approval to a proposed settlement. The judge will review the request and decide whether the settlement can move forward to the next stage. If approved, potential class members will generally receive information about the settlement and their rights, including any deadlines for taking action.

View all Updates

SPECTRUM PHARMACEUTICALS INC (SPPI) Class Action Lawsuit (August 2021)

Settlement

2:21cv1612 • August 31, 2021

Class Period Start

March 6, 2018

Class Period End

November 3, 2021

PSLRA Deadline

November 1, 2021

Case Allegations

10b5

Statutes of Repose

Mar 6, 2021

Country

United States

Court

Federal Court

Settlement Information

Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.

Claim Deadline

October 1, 2025

Settlement Fund

$15,950,000

Settlement Status

Final Approval

Settlement Class

All persons or entities that purchased or otherwise acquired Spectrum common stock between March 7, 2018, and August 5, 2021, inclusive.

Claim Administrator

Verita Global, LLC
P.O. Box 301171 Los Angeles, CA 90030-1171
+1 833-586-3555
[email protected]

Hearing Date

October 20, 2025

Opt-out Deadline

September 29, 2025

Settlement Note

Download here

Proof Of Claim

Download here

Docket History

Oct 27, 2025

Final Approval of Settlement

The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.

Sep 15, 2025

Motion for Final Approval of Settlement

The parties have asked the court to grant final approval of the proposed settlement. The judge will consider whether the settlement should be approved after reviewing the settlement terms and any objections. If approved, eligible investors who submit valid claims may receive a payment after the claims review and distribution process is completed.

Jun 16, 2025

Preliminary Approval of Settlement

The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.

Jun 16, 2025

Notice of Pendency

Jun 16, 2025

Proof of Claim Form

To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.

View all Updates

TOP